STAGE IVA OVARIAN CANCER AJCC V8
Clinical trials for STAGE IVA OVARIAN CANCER AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA OVARIAN CANCER AJCC V8 trials appear
Sign up with your email to follow new studies for STAGE IVA OVARIAN CANCER AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope: testing targeted drug before surgery for aggressive ovarian cancer
Disease control OngoingThis early study is testing whether a drug called olaparib can help shrink tumors before surgery in people newly diagnosed with advanced ovarian cancer that has a BRCA gene mutation. The trial involves about 15 participants who will take olaparib pills for up to two months before…
Matched conditions: STAGE IVA OVARIAN CANCER AJCC V8
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 20, 2026 14:47 UTC
-
Can blood tests help tame Chemo's painful side effects?
Knowledge-focused TerminatedThis study aims to see if doctors can reliably measure the amount of a common chemotherapy drug, paclitaxel, in a patient's blood. The goal is to learn if tracking these drug levels can help doctors adjust doses to better fight cancer while reducing a major side effect: nerve dam…
Matched conditions: STAGE IVA OVARIAN CANCER AJCC V8
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:43 UTC